Copyright: ©Author(s) 2026.
World J Gastrointest Pathophysiol. Jun 22, 2026; 17(2): 122029
Published online Jun 22, 2026. doi: 10.4291/wjgp.v17.i2.122029
Published online Jun 22, 2026. doi: 10.4291/wjgp.v17.i2.122029
Table 1 Characteristics of included clinical studies evaluating gut barrier dysfunction and multidrug-resistant bacterial translocation in critically ill adults
| Ref. | Country | Study design | ICU population | Organism/focus | Key findings |
| Thom et al[22], 2010 | United States | Observational cohort | ICU patients | Acinetobacter baumannii | Identical strains detected in GI colonization and bloodstream infection |
| Jung et al[20], 2010 | South Korea | Cohort | ICU patients | MDR Acinetobacter baumannii | Colonization associated with increased risk of bacteraemia |
| Giannella et al[17], 2014 | Italy | Prospective multicentre cohort | Rectal carriers | CRKP | Rectal colonization strongly predicted subsequent bacteraemia |
| Giacobbe et al[19], 2017 | Italy | Multicentre retrospective cohort | Colonized patients | CRKP | Prior infections predicted CRKP bacteraemia |
| Freedberg et al[11], 2018 | United States | Prospective observational study | ICU patients | Gastrointestinal microbiome colonization | GI pathogen colonization at ICU admission associated with subsequent infection and mortality |
| Amberpet et al[21], 2018 | India | Prospective study | Pediatric ICU patients | Vancomycin-resistant enterococci | Intestinal colonization identified as a major risk factor for MDR transmission |
| Zaborin et al[12], 2014 | United States | Microbiome observational study | Critically ill patients | Gut pathogen communities | Ultra-low-diversity gut microbiota associated with pathogen domination during critical illness |
| Silago et al[29], 2020 | Tanzania | Observational cohort | Critical care patients | MDR Gram-negative bacteria | Colonization and environmental contamination contributed to bacteraemia |
| Padar et al[31], 2021 | Estonia | Prospective ICU study | ICU patients | Citrulline/I-FABP | Biomarkers reflected intestinal injury in critical illness |
| Reintam Blaser et al[33], 2021 | Multicentre Europe | Prospective observational study | Critically ill patients | GI dysfunction | Developed gastrointestinal dysfunction scoring system |
| Chu et al[16], 2022 | China | Prospective cohort | ICU patients | CRE | Rectal colonization significantly associated with bloodstream infection |
| Garcia et al[13], 2022 | Spain | Prospective cohort | ICU patients | MDR bacteria/microbiome | Gut microbiome disruption associated with MDR colonization |
| Mu et al[23], 2022 | China | Molecular cohort study | Septic patients | Gut–blood pathogen concordance | Bloodstream pathogens genetically matched gut strains |
| Falcone et al[41], 2022 | Italy | Observational cohort | Severe COVID-19 ICU patients | MDR Klebsiella pneumoniae | Hypervirulent MDR strains spread in ICU population |
| Baek et al[14], 2023 | South Korea | Microbiome analysis | ICU patients | CRE | Dysbiosis associated with CRE colonization |
| Casale et al[40], 2023 | Italy | Cohort study | Hospitalized COVID-19 ICU patients | Carbapenem-resistant organisms | Colonization increased mortality and infection risk |
| Onuk et al[34], 2023 | Turkey | Prospective cohort | ICU patients | Citrulline/I-FABP | Biomarkers correlated with gastrointestinal dysfunction |
| Tyszko et al[35], 2023 | Poland | Observational study | Septic ICU patients | Citrulline/I-FABP | Biomarkers predicted gastrointestinal failure |
| Molinari et al[25], 2025 | International multicentre | Prospective observational study | Septic shock patients | Endotoxin activity | Higher endotoxin activity associated with organ failure and mortality |
| Yang et al[15], 2025 | China | Microbiome study | ICU patients | CRKP | Microbiome diversity associated with colonization resistance |
| Favier et al[18], 2026 | Argentina | Prospective surveillance study | ICU patients | Carbapenem-resistant Enterobacterales | Rectal and extra-rectal colonization predicted subsequent infection |
| Fang et al[28], 2025 | China | Molecular epidemiological study | Hospitalized patients | CRKP | Colonizing and bloodstream isolates showed plasmid and genotypic concordance |
| Nguyen et al[37], 2025 | France | Prospective clinical study | Septic/peritonitis patients | Endotoxin burden/HDL | HDL levels associated with reduced endotoxin burden in sepsis |
| Lyu et al[27], 2026 | China | Prospective cohort | ICU patients | CRE | Genotypic concordance between colonizing and infecting strains |
Table 2 Clinical studies evaluating the association between intestinal colonization and subsequent bloodstream infection in critically ill patients
| Ref. | Country | Study design | Population | Pathogen | Colonization site | Progression to infection | Key finding | ||||||
| Thom et al[22], 2010 | United States | Observational study | ICU patients | Acinetobacter baumannii | GI tract | Identical strains detected | GI colonization matched bloodstream isolates | ||||||
| Jung et al[20], 2010 | South Korea | Cohort | ICU patients | MDR Acinetobacter baumannii | Gastrointestinal tract | Increased risk of bacteraemia | Colonization independently predicted bloodstream infection | ||||||
| Giannella et al[17], 2014 | Italy | Prospective multicentre cohort | ICU patients with rectal colonization | CRKP | Rectal | Approximately 20%-40% bacteraemia | Rectal carriage strongly predicted CRKP bloodstream infection | ||||||
| Giacobbe et al[19], 2017 | Italy | Multicentre retrospective cohort | Colonized patients | CRKP | Rectal | Increased bacteraemia risk | Previous infections predicted CRKP bacteraemia | ||||||
| Freedberg et al[11], 2018 | United States | Prospective observational study | ICU patients | MDR gut pathogens | Gastrointestinal microbiome | Increased infection and mortality risk | GI pathogen colonization at ICU admission predicted adverse outcomes | ||||||
| Amberpet et al[21], 2018 | India | Prospective study | Pediatric ICU patients | Vancomycin-resistant enterococci | Intestinal tract | Increased colonization risk | Intestinal colonization facilitated MDR persistence and transmission | ||||||
| Silago et al[29], 2020 | Tanzania | Observational cohort | Critical care patients | MDR Gram-negative bacteria | GI/environmental | Transmission linked to bacteraemia | Colonization and cross-transmission contributed to infection | ||||||
| Chu et al[16], 2022 | China | Prospective cohort | ICU patients | CRE | Rectal | Approximately 15%-30% progression | Colonization associated with subsequent infection | ||||||
| Mu et al[23], 2022 | China | Molecular cohort | Septic ICU patients | Various pathogens | Gut microbiome | High strain concordance | Bloodstream pathogens genetically matched gut strains | ||||||
| Casale et al[40], 2023 | Italy | Cohort study | COVID-19 ICU patients | Carbapenem-resistant organisms | Gastrointestinal/respiratory | Increased mortality and infection risk | Colonization associated with superinfection and adverse outcomes | ||||||
| Fang et al[28], 2025 | China | Molecular epidemiological study | Hospitalized patients | CRKP | Gastrointestinal tract | Genotypic concordance observed | Colonizing and infecting strains shared homologous resistance plasmids | ||||||
| Lyu et al[27], 2026 | China | Prospective cohort | ICU patients | CRE | Rectal | Significant progression observed | Colonizing and infecting isolates showed genotypic concordance | ||||||
| Favier et al[18], 2026 | Argentina | Prospective surveillance study | ICU patients | Carbapenem-resistant Enterobacterales | Rectal and extra-rectal | Increased infection risk | Surveillance cultures predicted subsequent CRE infection | ||||||
Table 3 Biomarker and microbiome evidence associated with intestinal barrier dysfunction in critically ill patients
| Ref. | Country | Study design | Population | Biomarker/method | Key findings | Clinical implication |
| Wijnands et al[9], 2015 | Netherlands | Review/clinical synthesis | Sepsis patients | Citrulline metabolism | Reduced citrulline associated with enterocyte dysfunction | Marker of intestinal barrier injury |
| Blaser et al[10], 2019 | Europe | Observational clinical study | Critically ill patients | Citrulline, I-FABP | Low citrulline and elevated I-FABP associated with GI dysfunction | Biomarkers of mucosal injury |
| Padar et al[31], 2021 | Estonia | Prospective ICU study | ICU patients | Citrulline, I-FABP | Dynamic changes correlated with enteral nutrition and gut injury | Monitoring intestinal function |
| Reintam Blaser et al[33], 2021 | Multicentre Europe | Prospective multicentre study | Critically ill patients | GI Dysfunction Score | Developed standardized scoring for GI dysfunction | Clinical assessment tool |
| Garcia et al[13], 2022 | Spain | Prospective cohort | ICU patients | Gut microbiome sequencing | Reduced diversity associated with MDR colonization and infection | Dysbiosis associated with increased infection risk |
| Onuk et al[34], 2023 | Turkey | Prospective cohort | ICU patients | Citrulline, I-FABP, gastric ultrasound | Biomarkers correlated with gastrointestinal injury | Early detection of GI dysfunction |
| Tyszko et al[35], 2023 | Poland | Observational cohort | Septic ICU patients | Citrulline, I-FABP | Biomarkers associated with severity of gastrointestinal injury | Prognostic markers |
| Baek et al[14], 2023 | South Korea | Microbiome analysis | ICU patients | Microbiome sequencing | CRE colonization associated with microbiome disruption | Loss of colonization resistance |
| Yang et al[15], 2025 | China | Microbiome study | ICU patients | Microbiome diversity analysis | Preserved microbiome diversity associated with reduced CRKP colonization | Microbiome-mediated resistance |
- Citation: Dhotre SV, Dhotre PS, Mumbre SS, Nagoba BS. Gut barrier dysfunction and multidrug-resistant bacterial translocation in adult critical illness: Mechanistic insights from a systematic review. World J Gastrointest Pathophysiol 2026; 17(2): 122029
- URL: https://www.wjgnet.com/2150-5330/full/v17/i2/122029.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v17.i2.122029